Workflow
宁新新材(839719) - 2024 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders for the first nine months of 2024 was CNY -50,639,243.48, a decrease of 192.01% compared to CNY 55,034,159.54 in the same period of 2023[3] - The company's net profit for the third quarter of 2024 was CNY -32,294,594.66, a decline of 325.88% from CNY 14,297,260.91 in the same quarter of 2023[3] - The company reported a basic earnings per share of CNY -0.54 for the first nine months of 2024, compared to CNY 0.69 in the same period of 2023, reflecting a significant decline[3] - Net profit fell by 173.18% to -¥46,321,363.17, attributed to decreased operating revenue and reduced gross margin[6] - The net profit for the first nine months of 2024 was a loss of CNY 46,321,363.17, contrasting with a net profit of CNY 63,294,278.94 in the same period of 2023[27] - Operating profit for the first nine months of 2024 was a loss of CNY 51,363,915.54, compared to a profit of CNY 53,113,751.76 in the same period of 2023[28] - Total comprehensive income for the first nine months of 2024 was a loss of CNY 50,638,766.80, compared to a total comprehensive income of CNY 47,614,930.51 in the same period of 2023[29] Revenue and Costs - Operating revenue for the first nine months of 2024 was CNY 290,210,908.66, down 46.29% from CNY 540,336,468.74 year-on-year[3] - Operating revenue decreased by 46.29% to ¥290,210,908.66, primarily due to a decline in demand in the downstream photovoltaic and lithium battery industries, as well as production halts to reduce losses[5] - Total operating revenue for the first nine months of 2024 was CNY 290,210,908.66, a decrease from CNY 540,336,468.74 in the same period of 2023, representing a decline of approximately 46.3%[26] - Total operating costs for the first nine months of 2024 were CNY 313,845,894.85, compared to CNY 470,230,711.01 in the same period of 2023, indicating a decrease of about 33.2%[26] - The company reported a total equity of ¥913,194,204.55, down from ¥975,452,452.94, reflecting a decrease of approximately 6.38%[21] Cash Flow - The net cash flow from operating activities improved by 76.07%, reaching CNY -54,580,310.81 compared to CNY -228,072,225.45 in the previous year[3] - Cash flow from operating activities for the first nine months of 2024 was a net outflow of CNY 54,580,310.81, compared to a net outflow of CNY 228,072,225.45 in the same period of 2023[32] - Cash flow from investing activities showed a net outflow of -¥43,364,971.88, a 60.19% decrease, due to reduced capital expenditures on fixed assets[6] - Cash inflow from financing activities totaled ¥323,119,087.87, compared to ¥569,309,754.00 in the previous year, reflecting a decrease of approximately 43.3%[35] - The net cash flow from financing activities was positive at ¥52,811,075.02, down from ¥308,593,829.85 in the same period last year[35] Assets and Liabilities - Total assets as of September 30, 2024, amounted to CNY 1,973,337,890.88, representing a 3.00% increase from CNY 1,915,937,556.88 at the end of 2023[3] - The company's total liabilities to total assets ratio (consolidated) rose to 53.72% from 49.09% year-on-year[3] - Total liabilities reached ¥1,060,143,686.33, compared to ¥940,485,103.94, showing an increase of approximately 12.70%[21] - Short-term borrowings increased by 37.81% to CNY 419,508,919.07, primarily due to increased working capital needs[4] - The company has pledged assets totaling ¥322,474,835.66, which constitutes 16.34% of total assets[17] Shareholder Information - The total number of ordinary shares at the end of the period was 93,093,400, with 6,226 shareholders[9] - The company repurchased 835,493 shares, accounting for 0.90% of the total share capital, with a total payment of ¥6,641,642.22, representing 70.71% of the planned repurchase fund limit[16] - The company has a total of 40,583,164 shares held, with a 43.59% increase in shareholding compared to the previous period[11] Research and Development - Research and development expenses for the first nine months of 2024 were CNY 14,856,113.81, down from CNY 18,567,309.92 in the same period of 2023, a decrease of about 20.5%[26] - Research and development expenses for the first nine months of 2024 were CNY 9,833,312.82, down from CNY 13,137,795.19 in the same period of 2023, representing a decrease of 25.5%[28] Other Information - The company has completed the internal review process for all major events reported, including guarantees and share repurchase[13] - The company has no pledged or judicially frozen shares among the top shareholders[12] - The company has not engaged in any external borrowing during the reporting period[13] - The company has not reported any related party transactions or significant asset transfers[13] - The company has not disclosed any new product developments or market expansion strategies in the current reporting period[13]